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We describe a novel culture system for generating large
numbers of murine skin-associated mast cells and dis-
tinguish their characteristics from bone marrow-de-
rived cultured mast cells. Culture of day 16 fetal skin
single cell suspensions in the presence of interleukin-3
and stem cell factor allowed expansion and maturation
of mast cells in the presence of stromal cells. The aver-
age yield of mast cells after 2 wk was 7.3 million cells
per fetus at a purity of 96%. These fetal skin-derived
cultured mast cells increased their histamine content in
a time-dependent manner to 3.6 pg per cell after 2 wk
and 6.7 pg per cell after 4 wk. Phenotypic analyses re-
vealed much greater expression of CD49b and CD81
and lesser expression of CD77 and CD102 on fetal skin-
derived cultured mast cells as compared with bone
marrow-derived cultured mast cells. These ¢ndings
suggest a close similarity between fetal skin-derived
cultured mast cells and freshly isolated cutaneous mast
cells. Connective tissue mast cell characteristics of fetal
skin-derived cultured mast cells were evidenced by: (1)
their greater histamine content than bone marrow-de-
rived cultured mast cells; (2) the presence of heparin;
and (3) their degranulation in response to compound
48/80 and substance P. Importantly, fetal skin-derived
cultured mast cells secreted greater amounts of interleu-
kin-13 but much less MIP-1b and interleukin-6 than
bone marrow-derived cultured mast cells in response
to ionomycin. Thus fetal skin-derived cultured mast
cells have many characteristics distinct from bone
marrow-derived cultured mast cells and can be used as
a model of cutaneous mast cells to discern their func-
tions. Key words: chemokine/cytokine/fetus/mast cells/skin.
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S
tudies of mast cells in the skin have been hampered by
di⁄culties in their isolation. Most methods used to iso-
late mast cells from adult skin rely on mechanical and
enzymatic (by collagenase, hyaluronidase, DNase, etc.)
disruption of extracellular matrix and yield low num-
bers of nonpuri¢ed cells that are contaminated by large amounts
of tissue debris. The purpose of this study was to develop a mast
cell culture system that yields large numbers of puri¢ed cells that
resemble cutaneous mast cells (CMC).
Rodent mast cells are classi¢ed into connective tissue mast cells
(CTMC) and mucosal mast cells (MMC) (Stevens and Austen,
1989). CMC and peritoneal mast cells (PMC) represent CTMC,
and share morphologic, biochemical, and functional characteris-
tics such as many electron-dense granules, abundant presence of
histamine and heparin, and degranulation in response to cationic
secretagogues. On the other hand, MMC are represented by in-
testinal mast cells in mucosal epithelium and lamina propria after
infection of parasites. As isolation of MMC is not easy, bone mar-
row-derived cultured mast cells (BMMC) have been used as a
model of MMC. MMC and BMMC share some characteristics,
including predominant presence of chondroitin sulfate instead of
heparin. Recent analyses of mast cell protease (MCP) expression,
however, revealed di¡erences between MMC and BMMC
(McNeil et al, 1991; Ghildyal et al, 1992) and suggest that BMMC
are more similar to immature mast cells rather than to
MMC. Furthermore, analyses of MCP expression also disclosed
di¡erences among CTMC including CMC, PMC, and uterine
mast cells (Stevens et al, 1994; Hunt et al, 1997).
It has been well established that MMC and CTMC share the
common precursor of mast cells derived from hematopoietic
stem cells, and di¡erentiate according to their microenviron-
ments. BMMC injected into skin are shown to acquire character-
istics of CTMC. Several attempts have been made to induce
BMMC to acquire characteristics of CTMC in vitro. These
attempts include coculture with ¢broblasts (Levi-Scha¡er et al,
1986; Dayton et al, 1988) and addition of growth factors, including
stem cell factor (SCF) (Takagi et al, 1992) and nerve growth factor
(Matsuda et al, 1991). Although these studies succeeded in indu-
cing some characteristics of CTMC in some portion of mast cells,
we aimed to generate a more homogeneous population of mast
cells with characteristics of CMC, by starting the culture with
immature mast cells present in fetal skin instead of BMMC
already cultured ex vivo for several weeks.
Fetal skin can be easily disrupted by a single limited trypsini-
zation (Stevens and Austen, 1989) because of its intense cellularity
and limited ¢brosis. We determined that there are abundant
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numbers of immature mast cells in fetal skin and demonstrated
that these cells, when isolated and cultured for 2 wk, become ma-
ture mast cells. Addition of interleukin (IL)-3 and SCF to cell
suspensions from day 16 fetal skin allowed for expansion and ma-
turation of mast cells in the presence of stromal cells. In this study
we have characterized these fetal skin-derived cultured mast cells
(FSMC) and have compared them with BMMC.
MATERIALS AND METHODS
Mice C57BL/6, BALB/C (NCI-Animal Production Program, Frederick,
Maryland), and B6.SJL mice (Taconic, Germantown, NewYork) were used
in accordance with institutional guidelines.
Preparation of FSMC and BMMC Day 16 fetal trunk skin was
dissociated into single cells by limited trypsinization (0.25% trypsin
(Amersham Life Science, Cleveland, Ohio) for 20 min at 371C in Hank’s
balanced salt solution with calcium (Bio£uids, Rockville, Maryland)),
according to the method described by Jakob et al (1997). Erythrocytes
were lyzed using ACK lysing bu¡er (Bio£uids) and, after washing in
Hank’s balanced salt solution three times, cells were resuspended (5104
cells per mL for C57BL6 and SJL.B6 and 2104 cells per mL for BALB/
C) in complete RPMI (cRPMI) (RPMI1640; Life Technologies, Gai-
thersburg, Maryland) supplemented with heat-inactivated 10% fetal
bovine serum (Bio£uids, Rockville, Maryland), 2 mM L-glutamine (Life
Technologies), 10 mM nonessential amino acids (Life Technologies),
1antibiotic/anti-mycotic (Life Technologies), 10 mM sodium pyruvate
(Life Technologies), 25 mM HEPES bu¡er (Life Technologies), and 50
mM 2-mercaptoethanol (Sigma, St Louis, Missouri). We selected a lower
cell concentration for BALB/C cells than for C57/BL6 cells because of the
considerable proliferation of contaminating macrophages in the BALB/C
preparations. Fifty-¢ve milliliters of the cell suspension in each 162 cm2
T-£ask (Corning Inc., Corning, New York) was cultured in the presence
of murine recombinant IL-3 (10 ng per mL; Peprotech, Rocky Hill, NJ)
and recombinant SCF (10 ng per mL; Peprotech) at 371C for various
periods of time without changing the medium.
After various culture periods, nonadherent and loosely adherent cells
were harvested by gentle shaking and decanting the £asks. For density-
gradient centrifugation, Percoll density medium (Amersham Pharmacia
Biotech, Piscataway, New Jersey) was rendered isotonic by diluting
concentrated RPMI1640 (Sigma). The cells were resuspended at a
concentration of 107 cells per mL in culture media, layered on diluted
Percoll (40% isotonic Percollþ 60% culture medium), and centrifuged at
500 g for 10 min at room temperature. The cells at the interphase were
discarded and the cell-pellet at the bottom was used as FSMC.
For BMMC, bone marrow was aseptically £ushed from femurs and
tibias from 8 to 12 wk old mice, put into cRPMI, washed twice, and
resuspended in cRPMI supplemented with IL-3 and SCF cultured at a
density of 4105 cells per mL. Cells were recovered two times a week
by centrifugation and resuspended in fresh medium at a density of 4105
cells per mL.
Isolation of mast cells from adult mice PMC were obtained by
peritoneal lavage from 8 to 12 wk old C57BL/6 mice with 10 mL cold
phosphate-bu¡ered saline supplemented with 10% fetal bovine serum.
CMC were isolated from mouse ears using a previously described
enzymatic technique (He et al, 1990). Brie£y, ears of 8 to 12 wk old
C57BL/6 mice were cut into fragments and incubated in RPMI1640
medium supplemented with 25% fetal bovine serum, 1.5 mg collagenase
per mL (Sigma, catalog no. C7926), 0.5 mg hyaluronidase per mL (Sigma,
catalog no. H2251), and 0.5 mg per ml DNase I (Sigma catalog no. DN-25)
for 60 min at 371C. Dispersed cells were ¢ltered sequentially through 100
mm nylon mesh (Tetko Inc., Lancaster, NewYork) and 70 mm and 40 mm
cell strainers (Becton Dickinson Labware, Franklin Lakes, New Jersey), and
submitted to £ow-cytometric analyses.
Electron microscopy Cells were ¢xed with 2.5% glutaraldehyde,
washed in Millonig’s sodium phosphate bu¡er, and post¢xed in 1.0%
osmium tetroxide. After staining with 2.0% uranyl acetate, embedding in
Spurr’s resin, and ultra-thin sectioning, the cells were examined in a 100CX
Transmission Electron Microscope ( JEOL, Peabody, Massachusetts).
Histochemistry Cytospin preparations of mast cells were stained with
alcian blue 8 GX (Sigma) and safranin O (Sigma) according to Csaba’s
mast cell stain protocol after ¢xation in MFAA (85% methanol, 10%
formalin, and 5% glacial acetic acid) at 41C for 60 min (Csaba, 1969;
Culling, 1974). For the demonstration of heparin, cells were ¢xed with
5% glacial acetic acid in ethanol for 60 min, stained with 0.02%
berberine sulfate in double distilled water adjusted with citric acid to pH
4.0 for 20 min, and examined by £uorescence microscopy (Enerback, 1974).
Antibodies, £ow cytometry, and cell sorting Cells were subjected to
immuno£uorescence staining and analyzed with the FACSCalibur £ow
cytometer (Becton Dickinson, Mountain View, California). Propidium
iodide-permeable cells were excluded from the analyses. Anti-CD13 (R3-
242), anti-CD31 (MEC13.3), anti-CD45 (30-F11), anti-CD49b (DX5), anti-
CD81 (Eat1), anti-CD102 (3C4), anti-CD117 (2B8), and isotype controls
were purchased as puri¢ed or biotin-, £uorescein isothiocyanate-, phyco-
erythrin-, or allophycocyanin-conjugated monoclonal antibodies (MoAb)
from Pharmingen (San Diego, California). Anti-CD77 (38.13) MoAb was
purchased from Beckman Coulter (Brea, California). Anti-gp49B1 MoAb
(B23.1) was a kind gift from Dr Howard Katz at Harvard University.
Nonspeci¢c binding of the antibodies to the cell surface (via Fc receptors)
was blocked by incubation with puri¢ed anti-CD16/CD32 (2.4G2) prior to
staining with the antibody of interest.
To determine cell surface FceRI expression, we followed the protocol
described by Yamaguchi et al (1997). The cells were preincubated with
puri¢ed anti-CD23 (FceRII, clone B3B4, Pharmingen) and anti-CD16/32
(FcgRII/III, clone 2.4G2, Pharmingen) for 15 min to block low-a⁄nity
binding of IgE to molecules other than FceRI. The cells were then in-
cubated at 41C for 50 min with 10 mg per mL of mouse IgE anti-
dinitrophenyl (anti-DNP) MoAb (clone SPE7, Sigma), which was
previously depleted of dimeric or other complexed forms of IgE by
centrifugation at 20,000 g for 45 min. Binding of the monomeric IgE to
cell surfaces was detected by staining with biotin-conjugated rat-anti-mouse
IgE MoAb (clone R35-118, Pharmingen) together with allophycocyanin-
conjugated anti-CD117 MoAb, followed by staining with phycoerythrin^
streptoavidin (Pharmingen).
To determine histamine content in immature mast cells in day 16 fetal
skin, CD45þCD49bþCD117þ cells were sorted from the fetal skin cell
suspension using FACSVantage (Becton Dickinson).
ELISA Histamine and cytokine concentrations in the culture super-
natants or frozen-thawed cellular lysates were determined using a
histamine ELISA kit (Research Diagnostics, Flanders, New Jersey) and
ELISA kits for all the cytokines and a chemokine, including IL-2, IL-4,
IL-5, IL-6, IL-13, vascular endothelial growth factor, tumor necrosis
factor-a, and MIP-1b, according to the manufacturers’ instructions.
b-Hexosaminidase assay Mast cells were sensitized by incubation with
various concentrations of anti-DNP IgE (SPE7) (Sigma) for 18 h at 371C in
cRPMI containing 10 ng per mL of IL-3 and SCF. The cells were then
washed with Tyrode’s bu¡er (Sigma) containing 10 ng per mL of IL-3
and SCF, 0.04% bovine serum albumin, and 10 mM HEPES. The cells
were resuspended at 2104 cells per 100 mL for FSMC or 1105 cells per
100 mL for BMMC, aliquoted in triplicate into a 96 well U-bottom plate
(Costar, Corning, NewYork) and allowed to equilibrate at 371C for 10 min
prior to the addition of DNP-HSA (100 mL of 2 solutions) (Sigma),
substance P (ICN, Costa Mesa, CA), compound 48/80 (Sigma), or
Ionomycin (Sigma). After 30 min (for IgE), 20 min (for substance P),
15 min (for compound 48/80), or 10 min (for ionomycin) of incubation
at 371C, the plate was centrifuged at 290 g for 5 min at 41C. b-hexo-
saminidase activity of both the culture supernatant and the frozen-thawed
cell lysate was determined by the slightly modi¢ed protocol of Schwartz et
al (1979). Fifty microliter aliquots of the supernatant or cell lysate was
placed into wells of another 96 well plate together with 100 mL of
2.5 mM p-nitrophenyl-N-acetyl b-D glucosaminide (Sigma) solubilized
in 0.04 M citrate bu¡er adjusted with disodium phosphate to pH 4.5. After
incubation at 371C for 90 min, the reactions were terminated by addition
of 50 mL of 0.4 M glycine adjusted with sodium hydroxide to pH 10.7. The
colored product was measured using a Perkin Elmer (Wellesley, MA)
HTS7000 plate reader at 405 nm wavelength using a reference ¢lter of
570 nm. Percent b-hexosaminidase release was determined as the ratio be-
tween activity in the supernatant of tested cells and the frozen-thawed
lysate multiplied by 100.
Quantitative polymerase chain reaction (PCR) Relative expression
levels of MCP were determined by real-time PCR using SYBR Green I
Dye (PE Biosystems, Foster City, California) and an ABI Prism 7700
Sequence Detection System (PE Biosystems) according to the
manufacturer’s instructions. RNA was extracted from 14 d cultured
FSMC and from 4 to 5 wk cultured BMMC using TRIzol reagent (Life
Technologies), and puri¢ed using Oligotex mRNA isolation columns
(Qiagen, Valencia, California), and cDNA was synthesized using Mul-
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tiscribe reverse transcriptase (PE Biosystems) and random primers. Primers
corresponding to murine MCP (mMCP) and glyceraldehyde 3-phosphate
dehydrogenase (G3PDH) were designed using Primer Express software
(PE Biosystems) as follows:
mMCP-1: TTCCCTTGCCTGGTCCCTand
GTTTTCCCCCAGCCAGCT
mMCP-2: CATTGCCTAGTTCCTCTGACTTCA and
CCTGTTTTCCCCCATCCAG
mMCP-4: CTTCTGACTTTATCAAGCCGGG and
CACTCCAGTTCGCCCCC
mMCP-5: CCTGGGTTCCAGCACCAA and
GGCGGGAGTGTGGTATGC
mMCP-6: GCCCAGCCAATCAGCG and
CCAGGGCCACTTACTCTCAGA
mMCP-7: CATGCAGCCCCCGGTand
TTCCCATGTGCCTCCTGTC
mMCP-8: TTCCTCGGGTATTCACCAGAA and
GGGTTGTTGCAGGAGTTTCATT
mMCP-9: GGGTGGCCCATGGTATTGTA and
CGGGTGAAGATTGCAGGG
murine mast cell-carboxypeptidase A (mMC-CPA):
GCTACACATTCAAACTGCCTCCTand
GAGAGAGCATCCGTGGCAA
G3PDH: CGTGTTCCTACCCCCAATGT and
TGTCATACTTGGCAGGTTTCT.
As mMCP-7 transcripts in C57BL/6 possess a 98 bp deletion (Hunt et al,
1996), primers for mMCP-7 were designed upstream of the deletion so that
the deletion did not a¡ect the length of the ampli¢ed fragments.
Generation of PCR products was monitored and quanti¢ed in triplicate
using Sequence Detector software (PE Biosystems). Cycle threshold
numbers (Ct) were derived from the exponential phase of PCR
ampli¢cation. Fold di¡erences in expression of gene x in cell population y
and z were derived by 2k, where k¼ (CtxCtG3PDH)y ^ (CtxCtG3PDH)z.
RESULTS
In vitro generation of large numbers of mast cells from
fetal skin In fetal skin we previously identi¢ed immature mast
cells that express CD45, CD49b, and CD117 (Yamada et al in
preparation). These cells were so abundant that they comprised
4.870.8% (n¼ 5) of all the cells in day 16 fetal skin of C57BL/6
mice. We isolated CD45þCD49bþCD117þ cells using a £uor-
escence activated cell sorter, and found that these cells proliferate
in the presence of SCF in vitro.
We determined culture conditions that may enable the
preferential expansion of mast cells without their initial
isolation. Extensive studies revealed that a combination of 10 ng
IL-3 per mL and 10 ng SCF per mL consistently generated large
numbers of mast cells, and that initial seeding at low densities
(2^5104 cells per mL depending on strains of mice) resulted in
a higher purity of mast cells with fewer contaminating CD11bþ
macrophage-like cells (data not shown). The low seeding density
also eliminated the need to change the medium for several weeks
without signi¢cant loss of viability. After 2 wk of culture, about
40% of the total mast cells in the £asks could be harvested by
decantation after gently shaking the £asks. This nonadherent cell
population consisted mainly of mast cells (approximately 90%;
other cell types include macrophage-like cells). The remaining
60% of mast cells were adherent to the plastic along with
stromal cells. We did not use these adherent mast cells because
they could not be puri¢ed to greater than 90% even after
density gradient centrifugation.
Using these optimization steps, including Percoll density grad-
ient centrifugation, we succeeded in generating 7.372.1106
mast cells per fetus at a purity of 96.0%71.7% (n¼ 5; C57BL/
6), identi¢ed as CD45þCD117þ cells by £ow cytometry. As
30 fetuses can be easily manipulated, as many as 2108 skin-
associated mast cells could be generated in a single experiment.
We termed these cells FSMC.
Expression of functional FceRI on FSMC According to a
method described by Yamaguchi et al (1997) we determined
expression of high-a⁄nity IgE receptor, FceRI, on FSMC by
binding of IgE after blocking of FceRII, FcgRII, and FcgRIII,
all of which bind to IgE at low a⁄nity. FceRI was not
expressed on CD45þ CD49bþ CD117þ immature mast cells
freshly isolated from day 16 fetal skin (data not shown), but
induced upon culture in a time-dependent manner (Fig 1a^e).
Half of the cells come to express FceRI between 8 and 11 d, and
most of the cells expressed FceRI after 14 d at the same levels as
Figure1. FSMC express FceRI in a time-dependent manner and
degranulate upon cross-linking of FceRI. x- and y-axes of the histo-
grams represent expression levels of FceRI as determined by binding of
exogenous IgE, and cell numbers, respectively. Day 16 fetal skin cell sus-
pension from C57BL/6 mice was cultured with IL-3 and SCF for 5 d (a),
8 d (b), 11 d (c), 14 d (d), and 28 d (e), and CD45þCD117þ mast cells were
gated for the analyses. Bold lines correspond to the £uorescence intensity
of cells stained with anti-IgE antibody. Dotted lines correspond to the rat
IgG1 isotype control. Fourteen day cultured FSMC and 29 d cultured
BMMC from C57BL/6 mice were preincubated in the presence of 0.1 mg
anti-DNP IgE per mL for 18 h. After washing four times, the cells were
incubated with 10 ng DNP-conjugated HSA per mL for 30 min ( f ). b-hex-
osaminidase release was determined in triplicate. The ¢gure is representa-
tive of four similar experiments.
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those after 28 d. Cross-linking of FceRI induced degranulation
and release of the granular enzyme, b-hexosaminidase, from
FSMC (Fig 1f ).
FSMC increase their histamine content in a time-dependent
manner Histamine is one of the predominant mediators
released by mast cells. Greater amounts of histamine are stored
in CTMC (which are considered fully mature) than in BMMC
(Jakob et al, 1997). We sought to determine the degree of
maturation of FSMC by quantitating their histamine content by
ELISA. Histamine content of CD45þ CD117þ cells isolated
from day 16 fetal skin cell suspensions using a £uorescence
activated cell sorter was 0.5670.13 pg per cell (n¼ 2). FSMC
increased their histamine content in a time-dependent manner
to 3.670.7 pg per cell after 2 wk (n¼ 6), 5.770.3 pg per cell
after 3 wk (n¼ 3), and 6.771.0 pg per cell after 4 to 5 wk
(n¼ 6) in culture (Fig 2). Thus FSMC contain signi¢cantly
greater amounts of histamine than do BMMC (0.08670.014 pg
per cell after 4^5 wk of culture; n¼ 5). No signi¢cant di¡erences
were observed between histamine content of FSMC obtained
from either C57BL/6 or BALB/C (Fig 2).
Consistent with these ¢ndings and in contrast to BMMC
cultured for 30 d, electron microscopic analyses of 3 wk
cultured FSMC exhibited numerous electron-dense cytoplasmic
granules (Fig 3). The granules in 2 wk cultured FSMC were less
densely packed than those after 3 wk, but those after 3 and 4 wk
culture were indistinguishable.
Presence of heparin in FSMC Major proteoglycans produced
by mast cells di¡er between CTMC and BMMC (Stevens and
Austen, 1989). Alcian blue and safranin red stain MMC blue due
to the predominance of chondroitin sulfate, and stain CTMC red
due to the predominance of heparin. Although some of the
FSMC contained small numbers of blue granules in addition to
red granules, most of the FSMC stained red (Fig 4a), whereas
BMMC stained blue without any red granules (Fig 4c).
Staining with berberine sulfate also indicates the presence of
heparin in FSMC. Whereas FSMC were brightly stained (Fig
4b), the cytoplasmic staining in BMMC was less intense than
the background staining in their nuclei (Fig 4d). Thus the
presence of heparin, together with their having greater hista-
mine content, suggest that FSMC have characteristics similar
to CTMC.
FSMC but not BMMC degranulate in response to cationic
secretagogues Responses to cationic secretagogues such as
compound 48/80 and substance P are functional characteristics of
CTMC (Stevens and Austen, 1989). Whereas BMMC do not
degranulate in response to compound 48/80 at the concen-
trations less than 10 mg per mL or at less than 300 mM of
substance P, FSMC released more than 10% b-hexosaminidase
within 15 min at 5 mg per mL of compound 48/80 or at 300 mM
of substance P (Fig 5). Interestingly, the responses of FSMC to
Figure 2. Histamine content of FSMC increases with length of cul-
ture. FSMC from C57BL/6 or BALB/C mice were harvested after various
times in culture and cellular lysates were obtained by freezing and thawing.
Histamine content was determined using an ELISA kit and normalized to
the percentage of CD117þ cells by £ow cytometry.
Figure 3. Cytoplasmic granules in FSMC become more electron
dense and more densely packed with length of culture. Representa-
tive electron micrographs of C57BL/6-derived FSMC after 7 d (a), 14 d (b),
and 21 d (c), and BMMC cultured for 30 d (d ).
Figure 4. Demonstration of heparin in FSMC by histochemistry.
Fourteen day cultured FSMC (a,b) and 30 d cultured BMMC (c,d) from
C57BL/6 mice were stained with alcian blue and safranin red (a,c) or with
berberine sulfate (b,d).The red staining in a and the £uorescent staining in b
indicate that FSMC contain heparin.
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both compound 48/80 and substance P were enhanced by
overnight preincubation with IgE. The upregulation is not due
to nonspeci¢c activation of mast cells, because preincubation of
FSMC with IgE did not alter the responses to ionomycin.
Phenotypic di¡erences between FSMC and BMMC Exten-
sive phenotypic analyses of 14 d cultured FSMC and 4 to 5 wk
cultured BMMC revealed that the two are very similar with
regard to many cell surface markers. FSMC and BMMC
expressed similarly high levels of CD117 (c-kit) and CD13. In
addition, these two cell types expressed similar levels of CD31,
CD48, and gp49B1 recognized by B23.1 MoAb (Katz et al, 1996)
(data not shown).
DX5 MoAb has been widely used as a marker for natural killer
cells or natural killer T cells and was shown to recognize CD49b
(Arase et al, 2001). We unexpectedly found expression of this
marker on mast cells in fetal and adult skin and those in the
peritoneal cavity. Furthermore, this marker revealed a remar-
kable di¡erence between BMMC and FSMConly a minor
subpopulation of BMMC (5.572.0%, n¼ 7) recovered after 4
to 5 wk of culture expressed low levels of CD49b (mean
£uorescence intensity (MFI) 2.670.4, n¼ 7), whereas essentially
all the FSMC (98.871.1%, n¼ 7) expressed high levels of
CD49b (MFI 172764, n¼ 7) (Fig 6). This pattern of expression
of CD49b suggests that FSMC more closely resemble cutaneous
and PMC than BMMC.
Di¡erential expression of CD81 (a member of the TM4
superfamily) and CD102 (intercellular adhesion molecule-2) was
suggested from microarray analyses of FSMC and BMMC (data
not shown). Whereas essentially all the FSMC express CD81,
most BMMC did not express CD81. Furthermore, the expre-
ssion levels of CD81 on FSMC (MFI¼ 81) were higher than
those on BMMC (13) and closer in intensity to CMC (220) than
to PMC (1629) (Fig 6).
In contrast, the expression levels of CD102 on FSMC
(MFI¼ 5.4) were much less than on BMMC (23). PMC (1.8) and
CMC (1.9), both representing CTMC, also expressed signi¢cantly
lower levels of CD102 (Fig 6). The patterns of expression of
CD81 and CD102 suggest that FSMC more closely resemble
CTMC than BMMC.
When we assessed the intensity of staining with anti-CD77
(Gb3; globotriosylceramide) MoAb, we found that BMMC were
intensely positive (MFI¼ 2744), whereas FSMC expressed much
lesser amounts (33). Expression levels of CD77 on day 16 fetal
skin cells, PMC, and CMC were 3.2, 86, and 141, respectively.
FSMC secrete more IL-13 but less IL-6 and MIP-1b than
BMMC Mast cells are known to be a source of various
cytokines. In order to determine whether cytokines were
di¡erentially secreted by FSMC and BMMC, we measured
cytokine concentrations in the culture supernatant by ELISA
after various stimuli, including FceRI cross-linking, ionomycin,
and phorbol myristate acetate. Among these stimuli, incubation
with ionomycin caused maximal secretion of most cytokines.
Among the cytokines tested, IL-13, IL-6, and IL-4 were secreted
in large amounts (45 ng per million cells after 24 h incubation)
(Fig 7). FSMC and BMMC also secreted similar amounts of
GM-CSF and tumor necrosis factor-a (data not shown). IL-4
secretion was variable, and was not signi¢cantly di¡erent when
FSMC and BMMC were compared after repeated experiments.
Both in C57BL/6 and BALB/C mice, FSMC expressed larger
amounts of IL-13 than did BMMC. In contrast, whereas
BMMC secreted large amounts of MIP-1b, FSMC produced
virtually no MIP-1b. BMMC also secreted signi¢cantly larger
amounts of IL-6 than did FSMC (Fig 7).
Figure 5. FSMC but not BMMC respond to cationic secretagogues.
Fourteen day cultured FSMC and 30 d cultured BMMC from C57BL/6
mice were preincubated in the presence or absence of 0.3 mg IgE per mL
for 18 h. After washing three times, the cells were incubated with various
concentrations of compound 48/80, substance P, and ionomycin, for 15, 20,
and 10 min, respectively. Each bar represents mean7SD of the percentages
of b-hexosaminidase released as determined in triplicate. The ¢gure is a
representative result of three experiments. The p-value was calculated
according to the Student’s paired t test (po0.01; po0.05 vs. cells prein-
cubated in the absence of IgE).
Figure 6. Phenotypic characteristics of FSMC compared with other
mast cells.Thirty day cultured BMMC,14 d cultured FSMC, PMC, CMC
from ears, and immature mast cells from day 16 fetal skin of C57BL/6 mice
were compared using various phenotypic markers. Each histogram was
gated for CD45þ CD117þ mast cells, and the dotted lines correspond to
the relevant isotype control. Numbers in each column correspond to MFI.
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FSMC and BMMC di¡erentially express MCP mRNA As
mMCP have been reported to be di¡erentially expressed among
various subsets of mast cells, we determined the relative gene
expression levels of mMCP between FSMC and BMMC using
quantitative reverse transcription^PCR. As shown in Fig 8, 14d
cultured FSMC expressed higher levels of mMCP-1, -2, -4, -5,
-6, -7, and mMC-CPA than did BMMC in all the strains tested.
Whereas mMCP-1, -2, and -7 exhibited the highest values of
relative gene expression (more than 1000-fold in FSMC as
compared with BMMC) in C57BL/6 and SJL.B6 mice, mMCP-
4 and -9 exhibited the highest values in BALB/C mice. Increases
of mMCP-5, -6, and -CPA mRNA in FSMC were less than 10-
fold as compared with those in BMMC in all strains tested. Both
FSMC and BMMC expressed low levels of mMCP-8, and the
relative expression levels between the two were not consistent.
DISCUSSION
FSMC, generated by a novel culture system described herein, ex-
hibited phenotypic, morphologic, biochemical, and functional
characteristics distinct from BMMC. Our studies suggest that
FSMC most resemble CMC.
The ¢ndings identify several distinct phenotypic di¡erences
between BMMC and FSMC. CD49b, together with CD29, con-
stitutesVLA2, which binds to extracellular matrix, including col-
lagen and laminin. CD49b as determined by DX5 MoAb was
highly expressed on PMC, CMC, and FSMC but much less on
BMMC. In addition, none of the murine mast cell lines tested,
including PT18, p-815, MC/9, 10P-2, 10P-12, and 11PO-1, ex-
pressed CD49b (data not shown). Thus, among these cultured
mast cells, FSMC are most similar to CMC in terms of CD49b
expression.
Arase et al (2001) reported that expression levels of CD49b (de-
termined using the DX5 MoAb) on natural killer cells decrease
depending on the duration of culture.We observed similar ¢nd-
ings for BMMC. CD49b was expressed at low levels on early
(1^2 wk) cultures of BMMC but became essentially negative
after 4 to 5 wk. In contrast, expression levels of CD49b on FSMC
were not altered on extended culture that was maintained for up
to 7 wk without subculture (data not shown).
Greater expression of CD81 and lesser expression of CD102 on
FSMC, as compared with BMMC, also suggests a closer similar-
ity of FSMC to CTMC, CMC, and PMC. CD81, a member of
theTM4 superfamily, inhibits FceRI-mediated mast cell degranu-
lation in rats (Fleming et al, 1997). Expression levels of CD81 on
CMC, as determined by MFI, were signi¢cantly less than on
PMC and comparable with the expression on FSMC. Thus
CD81 expression suggests that FSMC resemble CMC more clo-
sely than PMC.
CD102 (intercellular adhesion molecule-2) is a ligand for leu-
kocyte integrins CD11a/CD18 (LFA-1) and is similar to CD54
(intercellular adhesion molecule-1) and CD50 (intercellular adhe-
sion molecule-3). CD50, although not being identi¢ed in mice, is
di¡erentially expressed on lung mast cells (positive) and CMC
(negative) in human beings (Ghannadan et al, 1998). As the extra-
cellular portion of CD102 shares 37% identity with the two
membrane-distal immunoglobulin superfamily domains of
CD50 in human beings, the functional relevance of negative ex-
pression of human CD50 and of mouse CD102 on CMC may be
important.
It has been established that BMMC cocultured with 3T3 ¢bro-
blasts acquire some characteristics of CTMC as evaluated by his-
tamine content, heparin synthesis (Levi-Scha¡er et al, 1986),
glycolipid expression (Katz et al, 1988; Raizman et al, 1990), MCP
expression (Sera¢n et al, 1987), and responses to polycationic se-
cretagogues (Sakaguchi et al, 1992). High doses of SCF (50 ng
per mL) were shown to induce similar levels of heparin synthesis
by BMMC as determined by biochemical analysis of 35S-labeled
proteoglycans (Tsai et al, 1991). These methods could not induce
all the cells to become CTMC, however, resulting in a heteroge-
neous population; for example, after culture with 50 ng per mL
of SCF for 4 wk, 3373% of BMMC remained negative for
safranin red, and only 2072% of the cells contained more safra-
nin-positive (heparin) granules than alcian blue-positive granules
(chondroitin sulfate) (Tsai et al, 1991); 44716% of the BMMC
also failed to be stained by berberine sulfate (Tsai et al, 1991). Po-
sitive staining with safranin of BMMC cocultured with 3T3 was
reported in more than 50% of cells after 2 wk and in 7377%
after 3 wk (Levi-Scha¡er et al, 1986). In contrast, FSMC exhibited
greater homogeneity, more than 95% of the cells being regularly
positive either with safranin red or berberine sulfate.
Figure 8. Increased expression of various MCP by FSMC. RNA pur-
i¢ed from 14 d cultured FSMC and 5 wk cultured BMMC from three
strains of mice, BALB/C, C57BL/6, and SJL.B6, were subjected to quanti-
tative reverse transcription^PCR using SYBR Green I Dye. The relative
gene expression levels were determined in triplicate by di¡erences of cycle
threshold numbers as described in Materials and Methods. The ¢gure is a
representative result of three similar experiments.
Figure 7. FSMC and BMMC di¡erentially secrete cytokines in
response to ionomycin. Eighteen day cultured FSMC and 4 to 5 wk
cultured BMMC from C57BL/6 or BALB/C were resuspended and cul-
tured in the presence of 1 mM ionomycin at 1106 cells per mL for 24 h.
Cytokine concentrations in the culture supernatants were determined in
duplicate by ELISA. Each bar represents mean7SD of three independent
experiments. The p-value was calculated according to the Student’s paired
t test.
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Levi-Scha¡er et al (1986) reported that 3 wk cultured BMMC
contained 0.1870.09 pg per cell of histamine. It increased to
2.7770.91 pg per cell in the adherent cells and 3.0071.61 pg per
cell in the nonadherent cells after 2 wk of coculture with 3T3
¢broblasts. Tsai et al (1991) reported that 4 wk cultured BMMC
contained 0.0870.02 pg per cell of histamine. This increased to
2.270.4 pg per cell after 4 wk of culture in 50 ng per mL of
SCF. In order to obtain larger numbers of BMMC and compare
them with FSMC, we cultured BMMC in the presence of 10 ng
per mL of SCF and IL-3. SCF at this low dose, however, did not
induce di¡erentiation into CTMC as compared with BMMC
cultured with IL-3 alone. These cells (BMMC in IL-3 and SCF)
were not stained with safranin and their histamine content after 4
to 5 wk of culture remained as low as 0.08670.014 pg per cell. In
contrast, FSMC contained 3.670.8 pg per cell of histamine after
2 wk and 6.370.6 pg per cell after 4 to 5 wk. 3T3 ¢broblasts have
also been used with mast cells other than BMMC. Dayton et al
(1988) succeeded in increasing cellular histamine content of
spleen-derived mast cells to 7.074.0 mg per 106 cells after 4 wk
of coculture with 3T3, but only 55713% of the mast cells be-
came predominantly safranin positive.These ¢ndings suggest that
FSMC are more potentially useful than other models for generat-
ing CTMC in vitro, in terms of their greater homogeneity and
maturity.
Katz et al demonstrated di¡erential expression of glycolipids by
PMC as compared with BMMC even after coculture with ¢bro-
blasts (Katz et al, 1988; Raizman et al, 1990). Mast cells recovered
after 21 d of coculture with 3T3 di¡ered from PMC with respect
to the presence of lactosylceramide, globotriosylceramide (Gb3¼
CD77), globotetraosylceramide (Gb4), and by the absence of glo-
bopentaosylceramide (Forssman antigen). Our FACS data re-
vealed much lower levels of CD77 expression on FSMC and
PMC as compared with BMMC. Our preliminary analysis of
glycolipids using thin-layer chromatography revealed several dis-
tinct bands corresponding to gangliosides and neutral glycolipids,
which were expressed predominantly by FSMC and much less by
BMMC (data not shown).
Mast cell secretory granule proteases are di¡erentially ex-
pressed in di¡erent tissues of various strains of mice. Di¡erences
between BMMC and MMC have been suggested because of the
greater expression of mMCP-5 and mMC-CPA and lesser ex-
pression of mMCP-1 and mMCP-2 by BMMC (McNeil et al,
1991; Ghildyal et al, 1992). In addition, BALB/C BMMC cultured
with IL-3 and SCF express high levels of mMCP-5 and mMC-
CPA mRNA (Gurish et al, 1992), whereas BALB/C CMC express
high levels of mMCP-2, mMCP-4, mMCP-6, and mMCP-7 in
addition to mMCP-5 and mMC-CPA (Stevens et al, 1994). Im-
portantly, mMCP-7 is not expressed by PMC. Therefore, the re-
markable upregulation of mMCP-2, mMCP-4, and mMCP-7 by
FSMC compared with BMMC suggests similarities between
FSMC and CMC. A lesser amount of mMCP-2 upregulation in
BALB/C compared with B6 strains is also consistent with pre-
vious ¢ndings using CMC (Stevens et al, 1994). Although
mMCP-9 is not expressed by CMC and thought to be speci¢c
to uterine mast cells (Hunt et al, 1997), we found that FSMC ex-
pressed large amounts of mMCP-9 mRNA in all strains tested.
Polycationic mast cell activators, such as compound 48/80 and
substance P, have been reported to activate CTMC but not MMC
and BMMC by interacting directly with the Gi family of
trimeric guanosine triphosphate-binding protein (Aridor et al,
1990), particularly Gi3a (Aridor et al, 1993). BMMC cocultured
for more than 3 wk with 3T3 in the presence of IL-3 have been
reported to acquire a sensitivity to compound 48/80, but the re-
sponse was weaker than that of PMC (Sakaguchi et al, 1992). Sub-
sequently, Ogasawara et al (1997) demonstrated that BMMC
obtained greater sensitivity to polycationic secretagogues after 4
to 6 d of coculture with 3T3 in the presence of SCF, whereas
3T3 or SCF alone was less e⁄cient.We demonstrated much greater
sensitivity of FSMC to compound 48/80 and substance P than
BMMC, and, as a novel ¢nding, have shown that the sensitivity
can be further increased by preincubation with IgE (without
antigen recognized by the IgE). Yamaguchi et al (1997) demon-
strated that preincubation with IgE enhances the expression of
FceRI on mast cells. Our ¢nding implies that CTMC may be-
come more sensitive to substance P secreted from peripheral
nerve endings or to other substances when the cells are previously
exposed to IgE (as in individuals with allergic diseases).
Stimulation of FSMC and BMMC with ionomycin induced
di¡erent pro¢les of cytokines and chemokines. IL-6 and MIP-
1b were preferentially secreted by BMMC. Downregulation of
MIP-1b secretion in FSMC was very dramatic and consistent,
and its mechanism and functional relevance needs to be eluci-
dated. On the other hand, FSMC secreted greater amounts of
IL-13. To our knowledge this is one of the ¢rst demonstrations
of IL-13 expression by murine mast cells at the protein level,
although it has been demonstrated in human mast cells (Kobaya-
shi et al, 1998; Toru et al, 1998). Interestingly, IL-13 has been
reported to suppress production of in£ammatory cytokines,
including IL-6 by macrophages (Doherty et al, 1993), and we
speculate that a similar mechanism may downregulate the pro-
duction of other cytokines by FSMC. IL-4 and IL-13 are both
critical mediators of T helper 2 responses (McKenzie et al, 1998)
and share many, but not all, biologic and immunoregulatory
functions (Chomarat and Banchereau, 1998). Bradding et al
(1995) reported that mast cells in human skin contain IL-4 but
very little IL-5 and IL-6, whereas mast cells in bronchial mucosa
contain IL-5 and IL-6. These ¢ndings are consistent with our re-
sults with regard to IL-6, but we did not observe signi¢cantly
increased expression of IL-4 by FSMC as compared with that ex-
pressed by BMMC. Interestingly, the amount of IL-13 secreted
by FSMC was several-fold greater than that of IL-4. As IL-4
and IL-13 exhibit similar e¡ects at similar doses (Chomarat and
Banchereau, 1998), it is possible that IL-13 derived from CMC
may be more important for the induction of T helper 2 responses
than previously thought.
In conclusion, FSMC exhibit many characteristics distinct
from BMMC and may serve as an excellent model for in vitro
studies of CTMC or skin-associated mast cells. From a clinical
point of view, we anticipate that FSMC may be more useful than
BMMC or other cell lines for screening drugs that may modify
functions of mast cells in skin.
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